Aktis Oncology Director Buys 20M Shares at $18 Each on 2026-01-12
ByAinvest
Monday, Jan 12, 2026 5:06 pm ET1min read
AKTS--
AKTS--
Aktis Oncology, Inc. [AKTS] announced that Director EcoR1 Capital, LLC acquired 2077779 shares at $18 per share on 2026-01-12, and an additional 144443 shares at the same price on the same day. Director, 10% Owner Kim Helen Susan purchased 22545 shares at $18 per share on 2026-01-12 and acquired 812455 shares at the same price on the same day. Furthermore, 10% Owner Vida Ventures II, LLC also bought 812455 shares at $18 per share on 2026-01-12 and acquired 22545 shares at the same price on the same day.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet